See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Feb. 6, 2007

Atrial Fibrillation or Cardiac Surgery High Cholesterol (Hyperlipidemia) Diabetes - Type 2

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Atrial Fibrillation or Cardiac Surgery

This is a study of a treatment for continuous atrial fibrillation as adjunct therapy to elective open heart surgery. Volunteers may qualify who are 18-80, have been in continuous atrial fibrillation for a minimum of three months, are scheduled for elective cardiac surgical procedure(s) to be performed on cardiopulmonary bypass, and have not had previous cardiac surgery.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat243.html or http://www.centerwatch.com/patient/studies/cat351.html.

-----

High Cholesterol (Hyperlipidemia)

Are you taking lipid lowering therapy to treat high cholesterol? If so, and you are at least 18 years old, you may qualify for this study of an investigational use of a marketed medication for high cholesterol.

The research site is in Arlington, Va.

More information

Please see http://www.centerwatch.com/patient/studies/cat170.html.

-----

Diabetes - Type 2

This is a 12-week study for people with type 2 diabetes that is inadequately controlled with metformin (Glucophage). Candidates 18-80 may be included who are on metformin of at least 1000 mg per day, have a HgbA1c in the range of 7-10, and do not have type 1 diabetes. Additional criteria may apply.

The research site is in Kansas City, Mo.

More information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.